Showing 3941-3950 of 8102 results for "".
Let’s Talk About Corneal Inlays
https://crstoday.com/topics/cornea/lets-talk-about-corneal-inlays/43516/Many patients seeking LASIK do not know about this presbyopia-correcting option.Laser Cataract Surgery in Pediatric Patients
https://crstoday.com/topics/general/laser-cataract-surgery-in-pediatric-patients/43225/Children are not little adults.Q&A With Glaukos CEO Thomas Burns
https://crstoday.com/topics/general/qa-with-glaukos-ceo-thomas-burns/42888/The process of validating a new category in glaucoma and transitioning from a startup to a public company.The STAAR Toric IOL
https://crstoday.com/topics/general/crst0506_14-html/41040/Current technique and results with a plate-haptic lens that effectively neutralizes corneal astigmatism at the time of cataract surgery.Topical Antibiotic Prophylaxis
https://crstoday.com/crst-issues/2005-feb/0205_f5_bucci-html/40873/Combining appropriate anti-infective selections with optimal dosing strategies can lower the risk of endophthalmitis.The Top Four Errors in Prescribing Antibiotics
https://crstoday.com/crst-issues/2005-feb/0205_f4_hwang-html/40872/New evidence suggests that the proper use of these agents can maximize their efficacy and limit resistance.Simultaneous Bilateral Cataract Surgery
https://crstoday.com/crst-issues/2003-aug/0803_041-html/40309/There are good reasons for experienced surgeons to consider the procedure in appropriate patients.AI Beyond the Clinic
https://crstoday.com/crst-issues/jan-2026/ai-beyond-the-clinic/54538/How regulation and reimbursement are accelerating AI and home monitoring.Endless and Essential: the Tug-of-War Over Off-Label Use
https://crstoday.com/topics/general/endless-and-essential-the-tug-of-war-over-off-label-use/43223/Will the pendulum swing once again?Is Resistance to Gatifloxacin and Moxifloxacin Here Already?
https://crstoday.com/topics/general/crst0407_16-php/41273/New evidence suggests that the incidence of in vitro resistance to these drugs is on the rise. How do we counter this trend?